Scientists Identify Thousands of New Proteins in Human 'Dark Proteome'

Discovery of the Dark Proteome

Scientists have uncovered thousands of previously unknown proteins located within the "dark proteome," a segment of the human genome historically considered to be nonfunctional. This discovery includes more than 1,700 new microproteins that researchers suggest could have significant implications for the study of human diseases, including cancer.

These proteins are characterized by their small size. Some of these proteins are produced by the thousands in every cell of the human body. Research indicates that certain proteins within this group, referred to as "peptideins," are essential for cellular survival; specifically, cells die when these small proteins are removed.

The TransCODE Consortium

The research was conducted by the TransCODE consortium, a collaborative effort involving several international institutions. The consortium includes experts from the European Bioinformatics Institute (EMBL-EBI), the Massachusetts Institute of Technology (MIT), the University of Michigan, the Institute for Systems Biology in Seattle, and the Princess Máxima Center for Pediatric Oncology in the Netherlands.

Historically, scientific efforts revealed that the human genome contains approximately 20,000 protein-coding genes. However, the dark proteome consists of proteins that were either overlooked or thought to be non-coding. Some of these unusual proteins are derived from unknown genetic instructions or possess unexpected modifications that cannot be explained by standard changes to DNA.

Implications for Disease and Cancer

The identification of these proteins is expected to reshape research into human diseases. Specifically, scientists are investigating the role these proteins play in cancer, though the exact mechanisms remain not fully understood.

Previous research into the role of a specific microprotein involved in medulloblastoma, a type of brain tumor, took nearly four years to complete. The discovery of thousands of new proteins provides a broader map for future investigations into how these molecules contribute to oncological processes.

Structural Challenges

While many proteins have known structures, the "entirely dark proteins" remain a significant puzzle for the scientific community. Researchers have questioned why the structures of these specific proteins have not yet been deduced and what their physical characteristics might be.

These proteins differ from typical protein patches of unknown structure, representing a distinct category of biological molecules that have remained hidden from traditional genomic and proteomic analysis.